Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Optimizing particle-mediated epidermal delivery of an influenza DNA vaccine in ferrets.

Yager EJ, Stagnar C, Gopalakrishnan R, Fuller JT, Fuller DH.

Methods Mol Biol. 2013;940:223-37. doi: 10.1007/978-1-62703-110-3_19.

PMID:
23104347
2.

GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates.

Loudon PT, Yager EJ, Lynch DT, Narendran A, Stagnar C, Franchini AM, Fuller JT, White PA, Nyuandi J, Wiley CA, Murphey-Corb M, Fuller DH.

PLoS One. 2010 Jun 8;5(6):e11021. doi: 10.1371/journal.pone.0011021.

3.

Epidermal delivery of protein and DNA vaccines.

Dean HJ.

Expert Opin Drug Deliv. 2005 Mar;2(2):227-36. Review.

PMID:
16296750
4.

Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system.

Dégano P, Sarphie DF, Bangham CR.

Vaccine. 1998 Feb;16(4):394-8.

PMID:
9607061
5.

Immunity obtained by gene-gun inoculation of a rotavirus DNA vaccine to the abdominal epidermis or anorectal epithelium.

Chen SC, Fynan EF, Greenberg HB, Herrmann JE.

Vaccine. 1999 Aug 6;17(23-24):3171-6.

PMID:
10462253
6.

Prospects for developing an effective particle-mediated DNA vaccine against influenza.

Yager EJ, Dean HJ, Fuller DH.

Expert Rev Vaccines. 2009 Sep;8(9):1205-20. doi: 10.1586/erv.09.82. Review.

PMID:
19722894
7.

Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis.

Dean HJ, Fuller D, Osorio JE.

Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):373-88. Review.

PMID:
12818623
8.

Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.

Kim YC, Yoo DG, Compans RW, Kang SM, Prausnitz MR.

J Control Release. 2013 Dec 10;172(2):579-88. doi: 10.1016/j.jconrel.2013.04.016. Epub 2013 Apr 30.

9.
10.

Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.

Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, Compans RW, York I, Kang SM, Donis RO.

Clin Vaccine Immunol. 2011 Dec;18(12):2010-7. doi: 10.1128/CVI.05206-11. Epub 2011 Oct 26.

11.

Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.

Cherukuri A, Servat E, Woo J.

Vaccine. 2012 Jan 5;30(2):237-46. doi: 10.1016/j.vaccine.2011.11.001. Epub 2011 Nov 12.

PMID:
22080173
12.

Immunogenic and protective properties of the first Kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in ferrets.

Tabynov K, Kydyrbayev Z, Sansyzbay A, Khairullin B, Ryskeldinova S, Assanzhanova N, Kozhamkulov Y, Inkarbekov D.

Virol Sin. 2012 Dec;27(6):345-52. doi: 10.1007/s12250-012-3272-7. Epub 2012 Nov 9.

PMID:
23180289
13.

Epidermal DNA vaccine for influenza is immunogenic in humans.

Drape RJ, Macklin MD, Barr LJ, Jones S, Haynes JR, Dean HJ.

Vaccine. 2006 May 22;24(21):4475-81. Epub 2005 Aug 19.

PMID:
16150518
14.

Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes.

Niesalla H, de Andrés X, Barbezange C, Fraisier C, Reina R, Arnarson H, Biescas E, Mazzei M, McNeilly TN, Liu C, Watkins C, Perez M, Carrozza ML, Bandecchi P, Solano C, Crespo H, Glaria I, Huard C, Shaw DJ, de Blas I, de Andrés D, Tolari F, Rosati S, Suzan-Monti M, Andrésdottir V, Torsteinsdottir S, Petursson G, Badiola J, Lujan L, Pepin M, Amorena B, Blacklaws B, Harkiss GD.

Vaccine. 2009 Jan 7;27(2):260-9. doi: 10.1016/j.vaccine.2008.10.042. Epub 2008 Nov 5.

PMID:
18984025
15.

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination.

Donnelly JJ, Friedman A, Ulmer JB, Liu MA.

Vaccine. 1997 Jun;15(8):865-8.

PMID:
9234535
16.

Delivery of noncarrier naked DNA vaccine into the skin by supersonic flow induces a polarized T helper type 1 immune response to cancer.

Lin CC, Yen MC, Lin CM, Huang SS, Yang HJ, Chow NH, Lai MD.

J Gene Med. 2008 Jun;10(6):679-89. doi: 10.1002/jgm.1183.

PMID:
18324638
17.

DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.

Gorres JP, Lager KM, Kong WP, Royals M, Todd JP, Vincent AL, Wei CJ, Loving CL, Zanella EL, Janke B, Kehrli ME Jr, Nabel GJ, Rao SS.

Clin Vaccine Immunol. 2011 Nov;18(11):1987-95. doi: 10.1128/CVI.05171-11. Epub 2011 Sep 14.

18.

H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines.

Cheng X, Eisenbraun M, Xu Q, Zhou H, Kulkarni D, Subbarao K, Kemble G, Jin H.

PLoS One. 2009;4(2):e4436. doi: 10.1371/journal.pone.0004436. Epub 2009 Feb 11.

19.

Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets.

Pillet S, Kobasa D, Meunier I, Gray M, Laddy D, Weiner DB, von Messling V, Kobinger GP.

Vaccine. 2011 Sep 9;29(39):6793-801. doi: 10.1016/j.vaccine.2010.12.059. Epub 2011 Jan 4.

PMID:
21211587
20.

Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.

Maltais AK, Stittelaar KJ, Veldhuis Kroeze EJ, van Amerongen G, Dijkshoorn ML, Krestin GP, Hinkula J, Arwidsson H, Lindberg A, Osterhaus AD.

Vaccine. 2014 May 30;32(26):3307-15. doi: 10.1016/j.vaccine.2014.03.061. Epub 2014 Mar 30.

Supplemental Content

Support Center